Board Leadership - Non-Legislative Trustees

Bruce Montgomery, M.D.

CEO, Cardeas Pharma

Dr. Bruce Montgomery is currently Chief Executive Officer of Cardeas Pharma and previously held the position of Senior Vice President, Respiratory Therapeutics at Gilead Sciences, Inc. Before his work with Gilead, Dr. Montgomery was the Founder and CEO of Corus Pharma of Seattle, a drug development company focusing on infectious disease and respiratory drugs. Corus Pharma was purchased by Gilead Sciences, Inc. in August of 2006. Until October 2000, Dr. Montgomery served as Executive Vice President of Research and Development at PathoGenesis Corporation.

Dr. Montgomery has extensive pharmaceutical company experience in drug development, operations and financing. Dr. Montgomery has been responsible for two complete drug approvals, started multiple other programs that have led to three additional FDA approvals. From 1985 to 1989, Dr Montgomery was co-inventor, and then led the effort to obtain FDA approval of aerosolized pentamidine, the second AIDS drug approved by the FDA.

In 1998, the Commissioner of the FDA recognized Dr. Montgomery with special citation for his industry leading acceleration in the development and approval of tobramycin solution for inhalation.

Dr. Montgomery received his Bachelor of Science in Chemistry in 1975 (Magna cum Laude, Outstanding Chemistry Major (Merck Award)), and Doctorate of Medicine in 1979 (Alpha Omega Alpha Honor Medical Society) from the University of Washington, Seattle. Dr. Montgomery is a board certified internist and pulmonologist.